GlassScriptPhysician profile
Amber Bartkowiak
NPI 1093164857
$4,921.22
in general payments reported to CMS, 2019-2025
33 companies · $963 in 2025
The $963 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $900 · 2022: $1,187 · 2023: $1,161 · 2024: $709 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,565 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,564.71 |
| Education | $268.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $909.48 | 2021-2025 | |
| Astellas Pharma US INC | $681.21 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $535.41 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $529.02 | 2021-2025 | |
| Myovant Sciences INC. | $343.04 | 2021-2022 | |
| Pfizer INC. | $332.41 | 2021-2024 | |
| Organon LLC | $189.99 | 2022-2025 | Nexplanon, Jada System |
| Exeltis, USA INC. | $137.89 | 2021-2025 | Slynd |
| Mylan Pharmaceuticals INC. | $129.78 | 2021-2022 | |
| Agile Therapeutics, INC. | $128.49 | 2021-2024 | Twirla |
| Optumhealth Care Solutions, LLC | $122.25 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Bayer Healthcare Pharmaceuticals INC. | $105.57 | 2021-2025 | |
| Daiichi Sankyo INC. | $98.48 | 2021-2024 | Injectafer |
| Therapeuticsmd, INC. | $72.58 | 2021-2022 | |
| Millicent US INC | $71.53 | 2024-2025 | Intrarosa, Femlyv, Femring |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $67.50 | 2021-2023 | Balcoltra |
| Coopersurgical, INC. | $49.73 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Scynexis, INC. | $47.97 | 2022 | |
| Dexcom, INC. | $47.43 | 2025 | Dexcom G6 Transmitter |
| Evofem Biosciences, INC. | $45.26 | 2021-2022 | |
| Exact Sciences Corporation | $43.68 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $41.92 | 2021-2023 | Thinprep 2000 Processor, Aptima |
| Urovant Sciences INC | $29.30 | 2022 | |
| Sage Therapeutics, LLC | $23.58 | 2025 | Zurzuvae |
| Biohaven Pharmaceutical Holding Company LTD. | $20.82 | 2022 | |
| Smith+Nephew, INC. | $17.48 | 2022 | |
| Kci USA, INC. | $16.07 | 2023 | Prevena |
| Merck Sharp & Dohme LLC | $15.95 | 2021 | |
| Teleflex LLC | $15.92 | 2025 | Quikclot |
| Gynesonics, INC. | $13.44 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Amgen INC. | $13.07 | 2024 | Evenity |
| Aspira Women'S Health INC | $12.61 | 2023 | Ova1 |
| Minerva Surgical, INC | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Bartkowiak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.